Mineralys Therapeutics Inc
NASDAQ:MLYS
Income Statement
Earnings Waterfall
Mineralys Therapeutics Inc
Income Statement
Mineralys Therapeutics Inc
| Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||
| Operating Expenses |
(31)
|
(46)
|
(62)
|
(67)
|
(85)
|
(105)
|
(134)
|
(168)
|
(192)
|
(201)
|
(203)
|
(184)
|
(171)
|
|
| Selling, General & Administrative |
(5)
|
(8)
|
(12)
|
(12)
|
(14)
|
(16)
|
(18)
|
(21)
|
(24)
|
(26)
|
(28)
|
(32)
|
(39)
|
|
| Research & Development |
(26)
|
(39)
|
(50)
|
(54)
|
(70)
|
(89)
|
(116)
|
(148)
|
(169)
|
(176)
|
(175)
|
(152)
|
(132)
|
|
| Operating Income |
(31)
N/A
|
(46)
-47%
|
(62)
-34%
|
(67)
-8%
|
(85)
-26%
|
(105)
-24%
|
(134)
-28%
|
(168)
-25%
|
(192)
-14%
|
(201)
-5%
|
(203)
-1%
|
(184)
+9%
|
(171)
+7%
|
|
| Pre-Tax Income | ||||||||||||||
| Interest Income Expense |
2
|
4
|
8
|
10
|
13
|
14
|
15
|
15
|
15
|
13
|
12
|
13
|
16
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
|
| Pre-Tax Income |
(30)
N/A
|
(42)
-42%
|
(55)
-29%
|
(57)
-4%
|
(72)
-27%
|
(91)
-26%
|
(120)
-32%
|
(153)
-28%
|
(178)
-16%
|
(188)
-6%
|
(191)
-1%
|
(171)
+10%
|
(155)
+10%
|
|
| Net Income | ||||||||||||||
| Income from Continuing Operations |
(30)
|
(42)
|
(55)
|
(57)
|
(72)
|
(91)
|
(120)
|
(153)
|
(178)
|
(188)
|
(191)
|
(171)
|
(155)
|
|
| Net Income (Common) |
(30)
N/A
|
(42)
-42%
|
(55)
-29%
|
(57)
-4%
|
(72)
-27%
|
(91)
-26%
|
(120)
-32%
|
(153)
-28%
|
(178)
-16%
|
(188)
-6%
|
(191)
-1%
|
(171)
+10%
|
(155)
+10%
|
|
| EPS (Diluted) |
-0.8
N/A
|
-1.03
-29%
|
-1.37
-33%
|
-1.43
-4%
|
-1.99
-39%
|
-2.02
-2%
|
-2.44
-21%
|
-3.07
-26%
|
-3.66
-19%
|
-3.54
+3%
|
-2.91
+18%
|
-2.42
+17%
|
-2.29
+5%
|
|